REGN vs SNY: stock comparison and AI forecast
Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
REGN Regeneron Pharmaceuticals, Inc.
- Price
- $961.26 +35.5% · 6M
- Market Cap
- $100.21B
- P/E Ratio
- 21.6x
- Size
- large-cap
- AI Forecast
SNY Sanofi
- Price
- $43.13 -7.4% · 6M
- Market Cap
- $106.33B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- REGN and SNY have similar market capitalizations ($100.21B and $106.33B).
- Over the last six months REGN returned +35.5% and SNY -7.4%.
- REGN yields 0.38% in dividends; SNY pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | REGN | SNY |
|---|---|---|
| Market Cap | $100.21B | $106.33B |
| P/E Ratio | 21.55x | – |
| P/B Ratio | 2.99x | – |
| Dividend Yield | 0.38% | – |
| EPS | $45.18 | – |
| Book Value/Share | $325.37 | – |
| Revenue/Share | $164.11 | – |
| FCF/Share | $37.16 | – |
Profitability & Margins
| Metric | REGN | SNY |
|---|---|---|
| ROE | 18.4% | 30.0% |
| ROA | 13.9% | 16.9% |
| ROIC | 12.7% | 20.7% |
| Operating Margin | 28.8% | – |
| Net Margin | 36.5% | – |
| EBT Margin | 33.6% | – |
| Tax Rate | 15.3% | – |
Financial Health
| Metric | REGN | SNY |
|---|---|---|
| Current Ratio | 3.35x | 1.09x |
| Quick Ratio | 2.89x | 0.73x |
| D/E Ratio | 0.33x | – |
| Financial Leverage | 1.33x | 1.78x |
| Interest Coverage | 21.1x | – |
| Working Capital | $14.59B | $3.06B |
Cash Flow
| Metric | REGN | SNY |
|---|---|---|
| Operating Cash Flow | $4.85B | $28.11B |
| Free Cash Flow | $3.83B | – |
| Capital Spending | -$1.02B | – |
| OCF Growth YoY | -4.4% | -11.9% |
| FCF Growth YoY | -9.4% | – |
| FCF/Sales | 22.6% | – |
| CapEx/Sales | 6.0% | – |
Operational Efficiency
| Metric | REGN | SNY |
|---|---|---|
| Asset Turnover | 0.38x | – |
| Receivables Turnover | 2.2x | – |
| Inventory Turnover | – | 3.8x |
| Fixed Assets Turnover | 3.0x | – |
| Days Sales Outstanding | 164 days | – |
| Days Inventory | – | 96 days |
Income Statement
| Metric | REGN | SNY |
|---|---|---|
| Total Revenue | $16.90B | – |
| Operating Income | $4.86B | $23.11B |
| Net Income | $6.17B | $24.28B |
| R&D Expense | $6.60B | $25.35B |
| SG&A Expense | $2.76B | $32.28B |
| Cost of Goods Sold | – | $44.17B |
Dividend & Shareholder Information
| Metric | REGN | SNY |
|---|---|---|
| Dividends Per Share | $3.72 | – |
| Payout Ratio | 8.2% | – |
| Shares Outstanding | 103M | 2465M |
| Net Income Growth | 220.3% | 5.1% |
| EPS Growth | 8.0% | – |
REGN vs SNY: stock comparison and AI forecast
Which is bigger, REGN or SNY?
REGN and SNY have similar market capitalizations ($100.21B and $106.33B).
Which stock performed better over the last six months, REGN or SNY?
Over the last six months REGN returned +35.5% and SNY -7.4%.
Which one does Intratio's AI model rank higher, REGN or SNY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.